Spacelabs Healthcare is recalling the Arkon Anesthesia System with Version 2.0 Software due to a software defect that may cause serious adverse health consequences, including hypoxemia and death, according to an FDA announcement.
Grastek, a sublingual allergen extract manufactured by Merck & Co Inc, has received FDA approval as an immunotherapy for the treatment of Timothy grass pollen-induced allergic rhinitis.
Health Care Service Corporation will begin covering FeNO testing for asthma diagnosis and management effective April 1, 2014, according to a press announcement by Aerocrine.
Doribax (doripenem), an antibacterial drug that has been used to treat patients who develop pneumonia while on ventilators, carries an increased risk of death and lower clinical cure rates compared to similar antibacterial drugs, according to the FDA.
The joint lawsuit from the Academy of Allergy & Asthma in Primary Care (AAAPC) and United Allergy Services (UAS) aims to resolve allegations of anti-competitive practices among the AAAAI, ACAAI, and JCAAI, according to a news release by AAAPC.
Researchers have found the Surgeon General’s report of 1964, which first outlined the dangers of smoking and led to the development of tobacco control efforts, is responsible for adding nearly 20 years of life to eight million Americans.
A new study from the University of Michigan finds that 44 percent of adults worry that the devices will encourage kids to use tobacco products.
The new guidelines and updated disease definition are intended to help doctors confirm a diagnosis of severe asthma, and address associated factors that make it difficult to treat.
The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, is for use in people 18 years of age and older who are at increased risk of exposure to the H5N1 influenza virus.
Commentary by the organization’s president and CEO notes the ongoing quality and safety problems in healthcare, despite substantial and concentrated efforts to resolve the problem.